Irvine

The trials here

What the 2 trials at this site are about, from their registry records.

Conditions

• Depression2 trials

Phase

• Phase 32 trials

Status

• Recruiting1 trial
• Withdrawn1 trial

Lead sponsor

• Neurocrine Biosciences2 trials

Running trials

• Recruiting

  Long-Term Study to Assess the Safety and Tolerability of NBI-1065845 as an Adjunctive Treatment in Participants With Major Depressive Disorder (MDD)

  NCT06966401· Phase 3· Neurocrine Biosciences· Source

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Depression1 recruiting

Closed trials

• Recruiting

  NBI-1065845-MDD3025: Study to Assess the Efficacy and Safety of NBI-1065845 as an Adjunctive Treatment in Participants With Major Depressive Disorder (MDD)

  NCT06911112· Phase 3· Neurocrine Biosciences· Source